EC Number   |
Title |
Organism |
|---|
   2.1.1.357 | Ash1l methylates Lys36 of histone H3 independently of transcriptional elongation to counteract polycomb silencing |
Mus musculus |
| 2.1.1.357 | H3K36 methyltransferases as cancer drug targets Rationale and perspectives for inhibitor development |
Homo sapiens |
| 2.1.1.357 | High yield recombinant expression and purification of oncogenic NSD1, NSD2, and NSD3 with human influenza hemagglutinin tag |
Homo sapiens |
| 2.1.1.357 | In vitro histone lysine methylation by NSD1, NSD2/MMSET/WHSC1 and NSD3/WHSC1L |
Homo sapiens |
| 2.1.1.357 | Methylation of histone H3 lysine 36 enhances DNA repair by nonhomologous end-joining |
Homo sapiens |
| 2.1.1.357 | NSD2 promotes ventricular remodelling mediated by the regulation of H3K36me2 |
Mus musculus |
| 2.1.1.357 | Nucleosome binding alters the substrate bonding environment of histone H3 lysine 36 methyltransferase NSD2 |
Homo sapiens |
| 2.1.1.357 | Structural insights into the regulation and the recognition of histone marks by the SET domain of NSD1 |
Homo sapiens |
| 2.1.1.357 | The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas |
Homo sapiens |
| 2.1.1.357 | The structure of NSD1 reveals an autoregulatory mechanism underlying histone H3K36 methylation |
Homo sapiens |
